StockData
BioHarvest Sciences Inc. logo

BioHarvest Sciences Inc. (BHST) stock

BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.32+0.09 (+7.32%)

Close on Nov 19, 2026Market cap $29.92MP/E –Yield –

BioHarvest Sciences net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$11.14M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.14M–
FY2024Dec 31, 2024-$12.91M–
FY2023Dec 31, 2023-$12.56M–

More BioHarvest Sciences figures

See a number that looks wrong?